Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study
Despoina Kalapanida,1 Flora Zagouri,1 Maria Gazouli,2 Andriani Tsiakou,3 Eleni Zografos,2 Constantine Dimitrakakis,4 Spyridon Marinopoulos,4 Aris Giannos,4 Theodoros N Sergentanis,1 Efstathios Kastritis,1 Evangelos Terpos,1 Meletios-Athanassios Dimopoulos11Department of Clinical Therapeutic, Alexand...
Main Authors: | Kalapanida D, Zagouri F, Gazouli M, Tsiakou A, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/evaluation-of-met-t1010i-and-met-rs40239-single-nucleotide-polymorphis-peer-reviewed-article-OTT |
Similar Items
-
Auto-renouvellement des cellules souches melanocytaires : rôle des kinases RAF et MET
by: Barbotin, Céline
Published: (2016) -
Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
by: Bylicki O, et al.
Published: (2020-06-01) -
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01) -
Tackling CASMI 2012: Solutions from MetFrag and MetFusion
by: Steffen Neumann, et al.
Published: (2013-08-01) -
Dégradation du récepteur tyrosine kinase Met par clivages protéolytiques
by: Ancot, Frédéric
Published: (2010)